People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).
The U.S. Preventive Services Task Force (USPSTF) recently reviewed the latest evidence on screening for chlamydia and gonorrhea and ultimately issued an update to their 2014 recommendation.
The new recommendation, published in JAMA, deems screening for chlamydia and gonorrhea "critical because these STIs often do not cause symptoms, which makes them harder to detect," according to USPSTF vice-chair Michael Barry, MD.
Are you seeing a rise in STI cases in your practice?
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More